These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 25447673
21. The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1). Johnson MA, Klickstein JA, Khanna R, Gou Y, Cure VCP Disease Research Consortium, Raman M. Neurobiol Dis; 2022 Jul; 169():105722. PubMed ID: 35405261 [Abstract] [Full Text] [Related]
22. Structural and functional deviations in disease-associated p97 mutants. Tang WK, Xia D. J Struct Biol; 2012 Aug; 179(2):83-92. PubMed ID: 22579784 [Abstract] [Full Text] [Related]
23. Cytokine profiling in patients with VCP-associated disease. Dec E, Rana P, Katheria V, Dec R, Khare M, Nalbandian A, Leu SY, Radom-Aizik S, Llewellyn K, BenMohamed L, Zaldivar F, Kimonis V. Clin Transl Sci; 2014 Feb; 7(1):29-32. PubMed ID: 24119107 [Abstract] [Full Text] [Related]
24. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice? Clemen CS, Winter L, Strucksberg KH, Berwanger C, Türk M, Kornblum C, Florin A, Aguilar-Pimentel JA, Amarie OV, Becker L, Garrett L, Hans W, Moreth K, Neff F, Pingen L, Rathkolb B, Rácz I, Rozman J, Treise I, Fuchs H, Gailus-Durner V, de Angelis MH, Vorgerd M, Eichinger L, Schröder R. Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2770-2777. PubMed ID: 30100055 [Abstract] [Full Text] [Related]
25. Cross-sectional study of patients with VCP multisystem proteinopathy 1 using dual-energy x-ray absorptiometry. Columbres RCA, Luu V, Nguyen M, Kimonis V. Muscle Nerve; 2024 Jun 18; 69(6):699-707. PubMed ID: 38551101 [Abstract] [Full Text] [Related]
26. Novel valosin containing protein mutation in a Swiss family with hereditary inclusion body myopathy and dementia. Peyer AK, Kinter J, Hench J, Frank S, Fuhr P, Thomann S, Fischmann A, Kneifel S, Camaño P, López de Munain A, Sinnreich M, Renaud S. Neuromuscul Disord; 2013 Feb 18; 23(2):149-54. PubMed ID: 23140793 [Abstract] [Full Text] [Related]
30. Another VCP interactor: NF is enough. Weihl CC. J Clin Invest; 2011 Dec 18; 121(12):4627-30. PubMed ID: 22105166 [Abstract] [Full Text] [Related]
31. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. Niwa H, Ewens CA, Tsang C, Yeung HO, Zhang X, Freemont PS. J Biol Chem; 2012 Mar 09; 287(11):8561-70. PubMed ID: 22270372 [Abstract] [Full Text] [Related]
32. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology. Nalbandian A, Llewellyn KJ, Kitazawa M, Yin HZ, Badadani M, Khanlou N, Edwards R, Nguyen C, Mukherjee J, Mozaffar T, Watts G, Weiss J, Kimonis VE. PLoS One; 2012 Mar 09; 7(9):e46308. PubMed ID: 23029473 [Abstract] [Full Text] [Related]
38. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. Neuromuscul Disord; 2009 Nov 09; 19(11):766-72. PubMed ID: 19828315 [Abstract] [Full Text] [Related]
39. Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants. Zhang T, Mishra P, Hay BA, Chan D, Guo M. Elife; 2017 Mar 21; 6():. PubMed ID: 28322724 [Abstract] [Full Text] [Related]